Literature DB >> 10858037

Poor reversal of low molecular weight heparin by protamine.

M Makris, R E Hough, S Kitchen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10858037     DOI： 10.1111/j.1365-2141.2000.1902_2.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

1.  A 1-year drug utilization evaluation of protamine in hospitalized patients to identify possible future roles of heparin and low molecular weight heparin reversal agents.

Authors:  Charles E Mahan
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300

2.  Monitoring of heparin and its low-molecular-weight analogs by silicon field effect.

Authors:  Nebojsa M Milovic; Jonathan R Behr; Michel Godin; Chih-Sheng Johnson Hou; Kristofor R Payer; Aarthi Chandrasekaran; Peter R Russo; Ram Sasisekharan; Scott R Manalis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

Review 3.  Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine.

Authors:  Jennifer A Frontera; John J Lewin; Alejandro A Rabinstein; Imo P Aisiku; Anne W Alexandrov; Aaron M Cook; Gregory J del Zoppo; Monisha A Kumar; Ellinor I B Peerschke; Michael F Stiefel; Jeanne S Teitelbaum; Katja E Wartenberg; Cindy L Zerfoss
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

Review 4.  A review of anticoagulation in patients with central nervous system malignancy: between a rock and a hard place.

Authors:  Dawn Swan; David Julian Seiffge; Jecko Thachil
Journal:  J Neurol       Date:  2020-03-02       Impact factor: 4.849

5.  Rational design of low-molecular weight heparins with improved in vivo activity.

Authors:  Mallik Sundaram; Yiwei Qi; Zachary Shriver; Dongfang Liu; Ganlin Zhao; Ganesh Venkataraman; Robert Langer; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-13       Impact factor: 11.205

Review 6.  Emergency management of hemorrhagic complications in the era of glycoprotein IIb/IIIa receptor antagonists, clopidogrel, low molecular weight heparin, and third-generation fibrinolytic agents.

Authors:  Walter S Schroeder; Pritesh J Gandhi
Journal:  Curr Cardiol Rep       Date:  2003-07       Impact factor: 2.931

7.  Reversal Activity and Toxicity of Heparin-Binding Copolymer after Subcutaneous Administration of Enoxaparin in Mice.

Authors:  Justyna Swieton; Joanna Miklosz; Shin-Ichi Yusa; Krzysztof Szczubialka; Dariusz Pawlak; Andrzej Mogielnicki; Bartlomiej Kalaska
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923

8.  Monitoring of anticoagulant therapy in heart disease: considerations for the current assays.

Authors:  Mohammadali Boroumand; Hamidreza Goodarzynejad
Journal:  J Tehran Heart Cent       Date:  2010-05-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.